P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

May 2006

Features

Utilization of Health Care Resources in a High-Risk Medicaid Population with Chronic Obstructive Pulmonary Disease

The authors present a study in which they sought to identify patterns of disparities in race and sex in the use of health care resources by Medicaid patients with COPD, a population composed predominantly of minorities, women, and children.
Fadia T. Shaya, PhD, MPH, Antoine C. El Khoury, PhD, Navendu D. Samant, BS, PhD Candidate, and Steven M. Scharf, MD, PhD

Meeting Highlights

55th Annual Scientific Session of the American College of Cardiology

Topics include therapies with atorvastatin for hypercholesterolemia and mixed dyslipidemia, aliskiren and darusentan for hypertension, perindopril for coronary artery disease, bivalirudin for acute coronary syndrome, atorvastatin for atrial fibrillation, and darbepoetin alfa and carvedilol for heart failure.
Lawrence M. Prescott, PhD, and Sharon L. Prescott

Lymphoma Seminar: Innovations in Therapy for Non-Hodgkin’s Lymphoma

Dr. Goldenberg reviews advances in the treatment of lymphoma, including chemotherapeutic agents, monoclonal antibodies, radiolabeled products, and antisense drugs.
Marvin M. Goldenberg, PhD, RPh, MS

Continuing Education Credit

National Guidelines for a Novel Therapy: Update on Clinical Trials and Experience Using Consensus Panel Recommendations for Incorporating Omalizumab into Asthma Management

A panel of experts in allergies and pulmonology discuss the appropriate use of omalizumab with respect to current asthma guidelines and review the drug’s ability to improve symptoms, reduce exacerbations, and decrease patients’ use of health care resources.
Mark J. Baumel, MD, Lawrence Du Buske, MD, Stanley J. Szefler, MD, Lanny Rosenwasser, MD, and David B. Nash, MD, MBA

Departments

Editorial

Northern Exposure

David Nash, MD, MBA discusses the Canadian Coordinating Office for Health Technology Assessment, a source of information on drugs, devices, and “best practices” in Canada.
David Nash, MD, MBA

Medication Errors

A Medication-Error Trifecta!

Matthew Grissinger, RPh, FASCP, alerts us to the confusion that can results when multiple, related errors occur simultaneously. Examples: when branded generic products are available from different manufacturers and when a drug is dispensed by its brand name and by its generic name to the same patient.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Raging Hormones: Wyeth Hopes FDA Will Stop Compounding Pharmacies from Selling Bioidentical Hormones

Stephen Barlas comments on Wyeth’s petition to the FDA to stop compounding pharmacies from selling bioidentical hormones to women.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest information about FDA approvals, drug indications, and devices.

Drug Forecast

Exenatide (Byetta), an Incretin Mimetic: The First in a New Therapeutic Class in the Treatment of Diabetes

The authors review exenatide (Byetta) for treating diabetes.
Sweta Chawla, PharmD